Themis Medicare Limited (NSE:THEMISMED)
India · Delayed Price · Currency is INR 101.73
-0.08 (-0.08%)
Jun 19, 2026, 3:30 PM IST
Themis Medicare Market Cap
Themis Medicare has a market cap or net worth of 9.39 billion as of June 18, 2026. Its market cap has decreased by -24.65% in one year.
Market Cap
9.39B
Enterprise Value
10.30B
Revenue
3.42B
Ranking
n/a
PE Ratio
821.24
Stock Price
101.73
Market Cap Chart
Since July 26, 2001, Themis Medicare's market cap has increased from 94.35M to 9.39B, an increase of 9,856.55%. That is a compound annual growth rate of 20.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 19, 2026 | 9.39B | 1.34% |
| Dec 31, 2025 | 9.27B | -61.73% |
| Dec 31, 2024 | 24.22B | 23.62% |
| Dec 29, 2023 | 19.59B | 58.02% |
| Dec 30, 2022 | 12.40B | 42.22% |
| Dec 31, 2021 | 8.72B | 162.07% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| RPG Life Sciences | 37.67B |
| Solara Active Pharma Sciences | 27.13B |
| Indoco Remedies | 21.69B |
| Beta Drugs | 20.09B |
| Sakar Healthcare | 17.88B |
| Windlas Biotech | 16.84B |
| Ind-Swift Laboratories | 16.25B |
| Jagsonpal Pharmaceuticals | 14.25B |